MultiQure S.A. (FRA:PQB)

Market Cap	8.68M +32.1%
Revenue (ttm)	n/a
Net Income	-2.50M
EPS	-0.37
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.6160
Previous Close	0.6410
Day's Range	0.6160 - 0.6160
52-Week Range	0.2432 - 1.7090
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 30, 2026

About MultiQure

MultiQure S.A., a biopharmaceutical company, engages in the research and development of biological drugs and medical devices for therapeutic use. Its therapeutic portfolio in the field of immuno-oncology includes PB003G, which targets the GARP-TGFβ1 complex; PB004, an anticancer drug based on an anti-ROR1 antibody; and PB003A, a therapy that targets the αVβ8 integrin. The company was formerly known as Pure Biologics S.A. and changed its name to MultiQure S.A. in August 2026. The company was founded in 2010 and is based in Wroclaw, Poland.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2010
• Country: Poland
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: PQB

Financial Performance

Financial numbers in PLN

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 27, 2026

Data Sources Report a data error